Stock listing
NASDAQ:RETA Reata Pharmaceuticals Inc Stock
Follow Reata Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:RETA
$172.36 USD
Close on Sep 26, 2023 · No longer trades
- Lowest – highest close
- $13.07 – $247.74 USDSince May 26, 2016 · lowest May 26, 2016 · highest Feb 4, 2020
Delisted NASDAQ:RETA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:RETA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Reata Pharmaceuticals Inc on 6ix
- Calls
- 10 calls with a replay · 10 with a transcript · latest May 10, 2023
- Decks
- 24 decks · latest May 10, 2023
Events
| Call | When | Status |
|---|---|---|
| Reata Pharmaceuticals (RETA) Q1 2023 Earnings Call | Wed, May 10, 2023 · 8:30 AM ET | Replay |
| Reata Pharmaceuticals (RETA) Q3 2022 Earnings Call | Tue, Nov 08, 2022 · 8:30 AM ET | Replay |
| Reata Pharmaceuticals (RETA) Q2 2022 Earnings Call | Mon, Aug 08, 2022 · 8:30 AM ET | Replay |
| Reata Pharmaceuticals (RETA) Q1 2022 Earnings Call | Tue, May 10, 2022 · 8:30 AM ET | Replay |
| Reata Pharmaceuticals (RETA) Q4 2021 Earnings Call | Mon, Feb 28, 2022 · 8:30 AM ET | Replay |
| Reata Pharmaceuticals (RETA) Q3 2021 Earnings Call | Mon, Nov 08, 2021 · 8:30 AM ET | Replay |
| Reata Pharmaceuticals (RETA) Q2 2021 Earnings Call | Mon, Aug 09, 2021 · 4:30 PM ET | Replay |
| Reata Pharmaceuticals (RETA) Q1 2021 Earnings Call | Thu, May 06, 2021 · 8:30 AM ET | Replay |
| Reata Pharmaceuticals (RETA) Q4 2020 Earnings Call | Mon, Mar 01, 2021 · 8:30 AM ET | Replay |
| Reata Pharmaceuticals (RETA) Q3 2020 Earnings Call | Mon, Nov 09, 2020 · 8:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 2023 Earnings Presentation | Earnings | 36 slides | May 10, 2023 |
| Corporate Update (February 2023) | Corporate update | 33 slides | Feb 28, 2023 |
| Q3 2022 Earnings Presentation | Earnings | 23 slides | Nov 8, 2022 |
| Q2 2022 Earnings Presentation | Earnings | 30 slides | Aug 8, 2022 |
| Q1 2022 Earnings Presentation | Earnings | 29 slides | May 10, 2022 |
| FY2021 Earnings Presentation | Earnings | 25 slides | Feb 28, 2022 |
| Q3 2021 Earnings Presentation | Earnings | 17 slides | Nov 8, 2021 |
| Q2 2021 Earnings Presentation | Earnings | 23 slides | Aug 9, 2021 |
| Q1 2021 Earnings Presentation | Earnings | 36 slides | May 6, 2021 |
| FY2020 Earnings Presentation | Earnings | 48 slides | Mar 1, 2021 |
All 24 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2021) | Investor deck | 53 slides | Jan 11, 2021 |
| Q3 2020 Earnings Presentation | Earnings | 41 slides | Nov 9, 2020 |
| Corporate Update (November 2019) | Corporate update | 17 slides | Nov 12, 2019 |
| Corporate Update (October 2019) | Corporate update | 15 slides | Oct 15, 2019 |
| Q2 2019 Earnings Presentation | Earnings | 15 slides | Aug 8, 2019 |
| Corporate Update (September 2018) | Corporate update | 16 slides | Sep 25, 2018 |
| Corporate Update (July 2018) | Corporate update | 22 slides | Jul 23, 2018 |
| Technical Presentation (May 2018) | Technical | 5 slides | May 25, 2018 |
| Corporate Update (May 2018) | Corporate update | 15 slides | May 25, 2018 |
| Technical Presentation (November 2017) | Technical | 30 slides | Nov 6, 2017 |
| 2017 American Society of Nephrology Meeting | Conference | 12 slides | Nov 3, 2017 |
| Technical Presentation (July 2017) | Technical | 13 slides | Jul 24, 2017 |
| Technical Presentation (June 2017) | Technical | 23 slides | Jun 2, 2017 |
| Technical Presentation (June 2017) | Technical | 13 slides | Jun 2, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Christy Oliger Other companies: Zenas BioPharma, Inc. (Director · Since at least Aug 13, 2026); Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); Nuvalent, Inc. (Director · Since at least Jun 18, 2025); LAVA Therapeutics NV (Director · Since at least Jan 1, 2025); Vera Therapeutics, Inc. (Director · Since at least Jun 7, 2024); Replimune Group, Inc. (Director · Since at least Dec 1, 2021); Karyopharm Therapeutics Inc. (Director · Since at least Aug 28, 2020); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past); Sierra Oncology Inc (Director · Jun 2, 2021 – Jul 1, 2022 · Past) | Director · Apr 15, 2021 – Sep 26, 2023 · Past |
| Rajiv Patni Other companies: Septerna, Inc. (Chief Medical Officer · Since at least Aug 24, 2026); BioXcel Therapeutics, Inc. (Director · Since at least Jan 15, 2025); Quince Therapeutics, Inc. (Director · Since at least Feb 15, 2024); Portola Pharmaceuticals Inc (EVP, CMO · Feb 3, 2020 – Jul 2, 2020 · Past); Adamas Pharmaceuticals Inc (Chief Medical Officer · Jun 8, 2015 – Apr 8, 2019 · Past); Ocera Therapeutics Inc (Chief Development Officer · Sep 2, 2014 – May 7, 2015 · Past) | EVP, Chief R&D Officer · Jun 12, 2023 – Sep 26, 2023 · Past |
| R Kent McGaughy Jr Other companies: Instil Bio, Inc. (Director · Since at least Mar 18, 2021); Apollo Endosurgery Inc (Director · Dec 29, 2016 – Apr 4, 2023 · Past) | Director · May 25, 2016 – Sep 26, 2023 · Past |
| Bhaskar Anand Other companies: Summit Therapeutics Inc. (Chief Accounting Officer · Since at least Apr 2, 2024) | SVP, Chief Accounting Officer · Nov 13, 2021 – Sep 26, 2023 · Past |
| Shamim Ruff Other companies: Sarepta Therapeutics, Inc. (SVP, Chief Regulatory Affairs · Oct 3, 2017 – May 22, 2018 · Past) | Director · Apr 15, 2021 – Sep 26, 2023 · Past |
| Andrea Loewen | SVP, Global Regulatory Affairs · Feb 7, 2022 – Sep 26, 2023 · Past |
| Dennis K Stone | Director · May 25, 2016 – Dec 7, 2016 · Past |
| Elaine Castellanos | VP, Chief Accounting Officer · Apr 8, 2019 – Jun 7, 2021 · Past |
| James Warren Huff | Chief Executive Officer, Director · May 25, 2016 – Sep 26, 2023 · Past |
| William Rose | Director · May 25, 2016 – Sep 26, 2023 · Past |
Log in to ask 6ix AI your own questions about Reata Pharmaceuticals Inc.